- Home
- MAA vs BBIO Comparison
MAA vs BBIO Comparison
Compare MAA & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAA
- BBIO
- Stock Information
- Founded
- MAA 1977
- BBIO 2015
- Country
- MAA United States
- BBIO United States
- Employees
- MAA 2532
- BBIO N/A
- Industry
- MAA Real Estate Investment Trusts
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MAA Real Estate
- BBIO Health Care
- Exchange
- MAA Nasdaq
- BBIO Nasdaq
- Market Cap
- MAA 19.0B
- BBIO 6.7B
- IPO Year
- MAA 1994
- BBIO 2019
- Fundamental
- Price
- MAA $162.66
- BBIO $34.67
- Analyst Decision
- MAA Buy
- BBIO Strong Buy
- Analyst Count
- MAA 20
- BBIO 12
- Target Price
- MAA $175.00
- BBIO $57.09
- AVG Volume (30 Days)
- MAA 930.1K
- BBIO 3.2M
- Earning Date
- MAA 04-30-2025
- BBIO 04-29-2025
- Dividend Yield
- MAA 3.75%
- BBIO N/A
- EPS Growth
- MAA 0.75
- BBIO N/A
- EPS
- MAA 4.81
- BBIO N/A
- Revenue
- MAA $2,196,688,000.00
- BBIO $127,415,000.00
- Revenue This Year
- MAA $2.65
- BBIO $13.67
- Revenue Next Year
- MAA $3.82
- BBIO $118.02
- P/E Ratio
- MAA $34.29
- BBIO N/A
- Revenue Growth
- MAA 1.55
- BBIO N/A
- 52 Week Low
- MAA $126.77
- BBIO $21.62
- 52 Week High
- MAA $173.38
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- MAA 51.32
- BBIO 49.67
- Support Level
- MAA $163.48
- BBIO $33.92
- Resistance Level
- MAA $166.04
- BBIO $39.16
- Average True Range (ATR)
- MAA 3.46
- BBIO 1.43
- MACD
- MAA 0.72
- BBIO -0.16
- Stochastic Oscillator
- MAA 53.18
- BBIO 31.05
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.